177 related articles for article (PubMed ID: 21854200)
1. The antiplatelet activity of camel urine.
Alhaidar A; Abdel Gader AG; Mousa SA
J Altern Complement Med; 2011 Sep; 17(9):803-8. PubMed ID: 21854200
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
4. Camel platelet aggregation responses and the antiplatelet effect of camel urine: comparison between black and white camels.
Al-Ghumlas AK
Heliyon; 2020 Oct; 6(10):e05353. PubMed ID: 33150215
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
6. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
[TBL] [Abstract][Full Text] [Related]
9. The ultrastructure of camel blood platelets: a comparative study with human, bovine, and equine cells.
Gader AG; Ghumlas AK; Hussain MF; Haidari AA; White JG
Platelets; 2008 Feb; 19(1):51-8. PubMed ID: 18231938
[TBL] [Abstract][Full Text] [Related]
10. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
12. Papaverine inhibits human platelet aggregation induced by ADP.
Serro-Azul MI; Bydlowski SP; Chamone DA
Braz J Med Biol Res; 1992; 25(5):521-8. PubMed ID: 1342229
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Thromb Res; 2009 Sep; 124(4):418-22. PubMed ID: 19250657
[TBL] [Abstract][Full Text] [Related]
16. Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line.
Alhaider AA; El Gendy MA; Korashy HM; El-Kadi AO
J Ethnopharmacol; 2011 Jan; 133(1):184-90. PubMed ID: 20883769
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiplatelet activity of flavonoids from Leuzea carthamoides.
Koleckar V; Brojerova E; Rehakova Z; Kubikova K; Cervenka F; Kuca K; Jun D; Hronek M; Opletalova V; Opletal L
Drug Chem Toxicol; 2008; 31(1):27-35. PubMed ID: 18161506
[TBL] [Abstract][Full Text] [Related]
18. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the antiplatelet effect of aspirin on human and bovine platelets.
Swier P; Mohammad SF; Olsen DB; Kolff WJ
ASAIO Trans; 1989; 35(3):205-8. PubMed ID: 2597445
[TBL] [Abstract][Full Text] [Related]
20. Influence of a low dosage of clopidogrel on platelet function in cats as measured by the platelet function analyser PFA-100 and the multiplate analyser.
Teuber M; Mischke R
Res Vet Sci; 2016 Dec; 109():149-156. PubMed ID: 27892864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
